All articles by Kavya Chivukula

Kavya Chivukula

2019 top news stories

Athersys reports positive data from MultiStem cell therapy trial and CRISPR and Vertex treat first patient in gene-editing therapy trial. wraps up the key headlines from 2019.

September’s top news stories

NIH kick starts hunt for neuroprotective stroke treatments and Denali begins dosing Parkinson’s patients in Phase Ib trial. wraps up the key headlines from September 2019.

IQVIA forms partnership to advance use of real-world data in trials

IQVIA has collaborated with Friends of Cancer Research to advance the use of real-world evidence (RWE) in clinical trials to better understand treatment outcomes over time.

Signant Health to assist Shanghai Mental Health Center in trial

Shanghai Mental Health Center (SMHC) has selected Signant Health to provide electronic informed consent for a neuroscience study on schizophrenia.

NIA to fund initiative to test new dementia care interventions

The National Institute of Aging (NIA) will invest up to $53.4m over five years to spur innovation and enhance care for people suffering from Alzheimer’s disease and related dementias.

AMRA partners with Micron to expand reach of trials in Japan

Sweden-based AMRA Medical will support its pharmaceutical and research customers in carrying out clinical trials in Japan after partnering with imaging contract research organisation (CRO) Micron.

KU Cancer Center secures funding to increase clinical trials reach

The University of Kansas Cancer Center and the Midwest Cancer Alliance has received a six-year grant to expand its clinical trials to rural communities in the US state of Kansas.

NIH grants fund to UC Irvine to boost clinical research in US

The University of California, Irvine’s (UC Irvine) Institute for Clinical & Translational Science has received a grant of $24m from the National Institutes of Health.

NIH kick starts hunt for neuroprotective stroke treatments

The US National Institute of Health (NIH) has launched a search for neuroprotective therapies to reduce ischemic brain injury.

Idorsia Pharmaceuticals selects Arkivum to preserve clinical data

Switzerland-based Idorsia Pharmaceuticals has selected Arkivum to protect and digitally store its clinical trial and research data.